Huron Consulting Group (NASDAQ:HURN) Price Target Raised to $167.00 at Barrington Research

Huron Consulting Group (NASDAQ:HURN) had its target price boosted by Barrington Research from $142.00 to $167.00 in a research note issued to investors on Thursday morning,Benzinga reports. Barrington Research currently has an outperform rating on the business services provider’s stock. Barrington Research also issued estimates for Huron Consulting Group’s Q1 2025 earnings at $1.14 EPS, Q2 2025 earnings at $1.82 EPS, Q3 2025 earnings at $1.95 EPS, Q4 2025 earnings at $2.10 EPS, FY2025 earnings at $7.00 EPS and FY2026 earnings at $8.03 EPS.

Several other brokerages also recently issued reports on HURN. Benchmark raised their price objective on shares of Huron Consulting Group from $140.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday. William Blair restated an “outperform” rating on shares of Huron Consulting Group in a research note on Wednesday. Truist Financial restated a “buy” rating and issued a $165.00 target price (up previously from $140.00) on shares of Huron Consulting Group in a research note on Wednesday. Wedbush started coverage on Huron Consulting Group in a research note on Monday, February 3rd. They set an “outperform” rating for the company. Finally, StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $151.75.

Huron Consulting Group Price Performance

Shares of NASDAQ HURN opened at $149.58 on Thursday. Huron Consulting Group has a fifty-two week low of $84.26 and a fifty-two week high of $153.77. The company has a market capitalization of $2.65 billion, a price-to-earnings ratio of 32.52 and a beta of 0.59. The company has a 50 day simple moving average of $126.33 and a two-hundred day simple moving average of $117.59. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61.

Huron Consulting Group (NASDAQ:HURN) last released its earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The company had revenue of $399.31 million for the quarter, compared to the consensus estimate of $380.62 million. Analysts expect that Huron Consulting Group will post 6.1 EPS for the current fiscal year.

Insider Activity at Huron Consulting Group

In other Huron Consulting Group news, Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $122.81, for a total transaction of $127,968.02. Following the sale, the director now owns 26,756 shares of the company’s stock, valued at $3,285,904.36. The trade was a 3.75 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John Mccartney sold 500 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.65, for a total value of $62,325.00. Following the transaction, the director now owns 56,688 shares of the company’s stock, valued at $7,066,159.20. This trade represents a 0.87 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,584 shares of company stock valued at $1,067,539 over the last ninety days. Corporate insiders own 2.02% of the company’s stock.

Institutional Investors Weigh In On Huron Consulting Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Dakota Wealth Management increased its stake in Huron Consulting Group by 4.0% during the 4th quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider’s stock valued at $280,000 after buying an additional 87 shares during the period. Assetmark Inc. boosted its holdings in shares of Huron Consulting Group by 7.0% in the third quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after acquiring an additional 90 shares in the last quarter. Summit Investment Advisors Inc. increased its stake in shares of Huron Consulting Group by 5.5% during the fourth quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider’s stock valued at $228,000 after acquiring an additional 96 shares during the period. Andina Capital Management LLC raised its holdings in Huron Consulting Group by 3.4% during the fourth quarter. Andina Capital Management LLC now owns 3,296 shares of the business services provider’s stock worth $410,000 after purchasing an additional 107 shares in the last quarter. Finally, Martingale Asset Management L P lifted its position in Huron Consulting Group by 0.5% in the third quarter. Martingale Asset Management L P now owns 20,479 shares of the business services provider’s stock worth $2,226,000 after purchasing an additional 110 shares during the period. 93.90% of the stock is currently owned by institutional investors.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.